Eam Investors, LLC Vericel Corp Transaction History

Eam Investors, LLC

$569 Million
Q1 2024

A detailed history of Eam Investors, LLC transactions in Vericel Corp stock. As of the latest transaction made, Eam Investors, LLC holds 83,527 shares of VCEL stock, worth $3.83 Million. This represents 0.76% of its overall portfolio holdings.

Number of Shares

83,527

Holding current value

$3.83 Million

% of portfolio

0.76%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$32.52 - $52.33 $2.72 Million - $4.37 Million	83,527 New	83,527 $4.35 Million
Q2 2023 Aug 11, 2023	BUY	$29.0 - $38.37 $818,815 - $1.08 Million	28,235 New	28,235 $1.06 Million
Q2 2021 Aug 13, 2021	SELL	$47.2 - $67.81 $3.33 Million - $4.79 Million	-70,648 Closed	0 $0
Q1 2021 May 11, 2021	SELL	$30.93 - $59.48 $2.81 Million - $5.4 Million	-90,859 Reduced 56.26%	70,648 $3.92 Million
Q4 2020 Feb 11, 2021	BUY	$18.53 - $31.5 $2.99 Million - $5.09 Million	161,507 New	161,507 $4.99 Million

Q2 2019 Aug 14, 2019	SELL	$15.01 - $18.89 $2.34 Million - $2.95 Million	-155,933 Closed	0 $0
Q1 2019 May 13, 2019	SELL	$16.23 - $20.29 $438,274 - $547,911	-27,004 Reduced 14.76%	155,933 $2.73 Million
Q4 2018 Feb 13, 2019	BUY	$10.77 - $18.44 $1.97 Million - $3.37 Million	182,937 New	182,937 $3.18 Million
Q3 2018 Nov 08, 2018	SELL	$9.1 - $14.8 $500,172 - $813,467	-54,964 Closed	0 $0
Q2 2018 Aug 03, 2018	SELL	$9.6 - $14.6 $3.68 Million - $5.6 Million	-383,252 Reduced 87.46%	54,964 $533,000
Q1 2018 May 14, 2018	BUY	$5.7 - $12.3 $1.86 Million - $4.01 Million	325,803 Added 289.83%	438,216 $4.36 Million
Q4 2017 Feb 12, 2018	SELL	$3.65 - $5.98 $163,505 - $267,880	-44,796 Reduced 28.49%	112,413 $613,000
Q3 2017 Nov 08, 2017	BUY	$3.0 - $6.0 $471,627 - $943,254	157,209	157,209 $943,000

Others Institutions Holding VCEL

# of Institutions

263

Shares Held

48.9M

Call Options Held

150K

Put Options Held

128K

View Full List

About Vericel Corp

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.16B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

More about VCEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eam Investors, LLC with notifications on news.

Account